KPMG’s survey of global medical device companies provides insights into the maturity and readiness of Regulatory Operations teams to drive additional value in their organizations. While it is now common for companies to have a Regulatory Operations function, the survey found that many still have a long way to go to drive operational transformation within their regulatory teams. Gaps remain related to roles and responsibilities, governance, metrics, and adoption of digital technologies.
As regulatory complexity increases, companies are rethinking their operational strategies to maximize the value delivered by Regulatory Affairs to the broader organization. Download our paper to learn more.